TABLE 2.
Adverse Events Reported in Patients With Primary Open Angle Glaucoma During Treatment With Omidenepag Isopropyl 0.002% Ophthalmic Solution
| Patients (n=50), n (%) | |
|---|---|
| Overall incidence | 23 (46.0) |
| Incidence by preferred term | |
| Hyperemia | 13 (34.2) |
| Iridocyclitis | 5 (13.2) |
| Vision blurred | 3 (7.9) |
| Visual acuity reduced | 2 (5.3) |
| Glare | 2 (5.3) |
| Periorbital swelling | 2 (5.3) |
| Myopia | 1 (2.6) |
| Halo vision | 1 (2.6) |
| Visual impairment | 1 (2.6) |
| Dry eye | 1 (2.6) |
| Ocular discomfort | 1 (2.6) |
| Diplopia | 1 (2.6) |
| Clavicle fracture | 1 (2.6) |
| Periarthritis | 1 (2.6) |
| Migraine | 1 (2.6) |
| Renal cyst | 1 (2.6) |
| Dermatitis contact | 1 (2.6) |